THERMO FISHER SCIENTIFIC INC.

For the period ended Mar 28, 2026. Filed May 1, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 28, 2026 · Filed May 1, 2026

TMO$718.20-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

	Three months ended
	March 28,	March 29,
(In millions except per share amounts)	2026	2025
Revenues
Product revenues	$6,277	$5,980
Service revenues	4,728	4,384
Total revenues	11,005	10,364
Costs and operating expenses:
Cost of product revenues	3,261	3,125
Cost of service revenues	3,314	3,004
Selling, general and administrative expenses	2,181	2,078
Research and development expenses	336	342
Restructuring and other costs	49	98
Total costs and operating expenses	9,142	8,648
Operating income	1,863	1,716
Interest income	233	203
Interest expense	(354)	(303)
Other income/(expense)	(9)	3
Income before income taxes	1,734	1,620
Benefit from/(provision for) income taxes	(70)	(95)
Equity in earnings/(losses) of unconsolidated entities	(8)	(14)
Net income	1,656	1,511
Less: net income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest	5	4
Net income attributable to Thermo Fisher Scientific Inc.	$1,651	$1,507
Earnings per share attributable to Thermo Fisher Scientific Inc.
Basic	$4.44	$3.99
Diluted	$4.43	$3.98
Weighted average shares
Basic	372	378
Diluted	373	379

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.